Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EXAS [NASD]
Exact Sciences Corporation
Healthcare | Diagnostics & Research | USA
statements
Index- P/E- EPS (ttm)-5.54 Insider Own0.60% Shs Outstand171.31M Perf Week-21.26%
Market Cap17.53B Forward P/E- EPS next Y-2.51 Insider Trans-27.05% Shs Float167.54M Perf Month-21.27%
Income-848.50M PEG- EPS next Q-0.78 Inst Own88.60% Short Float5.81% Perf Quarter-33.43%
Sales1.49B P/S11.75 EPS this Y-777.40% Inst Trans1.66% Short Ratio6.12 Perf Half Y-21.98%
Book/sh18.04 P/B5.48 EPS next Y25.90% ROA-7.30% Target Price170.63 Perf Year20.52%
Cash/sh10.38 P/C9.52 EPS next 5Y- ROE-13.10% 52W Range70.75 - 159.54 Perf YTD-25.40%
Dividend- P/FCF- EPS past 5Y-26.80% ROI-17.30% 52W High-38.05% Beta1.29
Dividend %- Quick Ratio3.70 Sales past 5Y106.80% Gross Margin76.20% 52W Low39.70% ATR5.98
Employees4800 Current Ratio3.80 Sales Q/Q57.70% Oper. Margin-29.60% RSI (14)23.80 Volatility7.51% 4.44%
OptionableYes Debt/Eq0.57 EPS Q/Q-601.40% Profit Margin-22.40% Rel Volume1.66 Prev Close104.50
ShortableYes LT Debt/Eq0.48 EarningsMay 04 AMC Payout- Avg Volume1.59M Price98.84
Recom1.60 SMA20-21.85% SMA50-22.79% SMA200-16.01% Volume2,636,523 Change-5.42%
Jan-28-21Initiated Truist Buy $226
Oct-29-20Downgrade UBS Buy → Neutral $125 → $140
Oct-28-20Downgrade Citigroup Buy → Neutral $120 → $140
Oct-08-20Resumed BTIG Research Buy $140
Apr-02-20Initiated Evercore ISI Outperform $70
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
Feb-26-19Upgrade Goldman Neutral → Buy $85 → $120
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
May-05-21 08:29AM  
Exact Sciences (EXAS) Q1 Earnings Top Estimates, Margins Down
Zacks
06:01AM  
Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy
Motley Fool
03:31AM  
Exact Sciences (EXAS) Q1 2021 Earnings Call Transcript
Motley Fool
May-04-21 06:09PM  
Shares of Cancer Researchers Exact Sciences and Invitae Are Sliding. Heres Why.
Barrons.com -7.58%
05:25PM  
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
Zacks
04:00PM  
Exact Sciences Announces First Quarter 2021 Results
PR Newswire
03:15PM  
EXACT Sciences Corp. to Host Earnings Call
ACCESSWIRE
May-03-21 06:00AM  
Exact Sciences to participate in May investor conferences
PR Newswire
Apr-28-21 06:00AM  
Cologuard® CRC Screening Test Most Cost-Effective Test in Medically Underserved Alaska Native People
PR Newswire
Apr-25-21 07:00AM  
3 High-Growth Stocks on Cathie Wood's Buy List Last Week
Motley Fool
Apr-22-21 08:31AM  
2 Cathie Wood Picks That Can Become Bigger Winners Than Tesla
Motley Fool
Apr-14-21 06:00AM  
Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope
PR Newswire
Apr-12-21 07:26AM  
How a Simple Blood Test Could Reduce Cancer Deaths
Barrons.com
Apr-08-21 06:00AM  
Exact Sciences schedules first quarter 2021 earnings call
PR Newswire
Apr-06-21 03:56PM  
FTCs Challenge of Illumina Is a Boost for Rivals in Cancer Test Race
Barrons.com
11:11AM  
Bear of the Day: Guardant Health (GH)
Zacks
Mar-29-21 12:07PM  
Is EXACT Sciences (EXAS) Stock A Buy or Sell?
Insider Monkey
Mar-26-21 12:17PM  
The Rockefeller Foundation teams up with testing companies to aid school reopenings
Yahoo Finance
Mar-23-21 12:56PM  
Is It Too Late to Buy EXACT Sciences (EXAS) Stock?
Insider Monkey
Mar-18-21 12:14PM  
Is Exact Sciences Corp. (EXAS) A Smart Long-Term Buy?
Insider Monkey
11:30AM  
Why Is Exact Sciences (EXAS) Down 8.9% Since Last Earnings Report?
Zacks
Mar-16-21 08:00AM  
Exact Sciences Has 2 Strategies - Bullish Fundamentals but Bearish Charts
TheStreet.com
Mar-09-21 10:19AM  
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
PR Newswire +6.34%
09:00AM  
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
Business Wire
08:37AM  
Feasibility Arrangement for Shelf-stable Powder Form of Messenger RNA COVID-19 Vaccine Candidate Announced by GreenLight Biosciences and TFF Pharmaceuticals
Business Wire
08:00AM  
Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF Pharmaceuticals
PR Newswire
Mar-08-21 06:49AM  
What Type Of Shareholders Make Up TFF Pharmaceuticals, Inc.'s (NASDAQ:TFFP) Share Registry?
Simply Wall St.
Mar-05-21 09:00AM  
TFF Pharmaceuticals to Present at Virtual Investor Conferences in March 2021
Business Wire
Mar-04-21 08:30AM  
TFF Pharmaceuticals Provides Update on Clinical Development Programs
Business Wire
Feb-22-21 06:00AM  
Exact Sciences to participate in March investor conferences
PR Newswire
Feb-21-21 06:17AM  
Adding $5,000 to These 2 Top Stocks Could Make You Richer in 2021 (and Beyond)
Motley Fool
Feb-17-21 03:01PM  
Why Exact Sciences Stock Sank Today
Motley Fool -8.61%
08:00AM  
Exact Sciences Drops on Earnings Loss, Lack of Visibility
TheStreet.com
07:26AM  
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Benzinga
06:30AM  
Exact Sciences (EXAS) Q4 2020 Earnings Call Transcript
Motley Fool
05:24AM  
Exact Sciences Falls 4% On Larger-Than-Feared 4Q Loss
SmarterAnalyst
Feb-16-21 09:22PM  
Exact Sciences Falls in After-Hours Trading on Q4 Results
Motley Fool
05:18PM  
Dow Jones Futures: Apple, Tesla Test Support As JPMorgan, Caterpillar Break Out; Six Key Earnings Late
Investor's Business Daily
04:45PM  
Recap: Exact Sciences Q4 Earnings
Benzinga
04:05PM  
Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope's Genomics Institute, TGen
PR Newswire
04:05PM  
Exact Sciences Announces Fourth Quarter 2020 Results
PR Newswire
02:45PM  
EXACT Sciences Corp. to Host Earnings Call
ACCESSWIRE
Feb-15-21 10:34AM  
A Preview Of Exact Sciences's Earnings
Benzinga
Feb-12-21 08:36AM  
Is a Surprise Coming for Exact Sciences (EXAS) This Earnings Season?
Zacks +5.68%
Feb-09-21 12:30PM  
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks
10:05AM  
Exact Sciences (EXAS) to Report Q4 Earnings: What's in the Cards?
Zacks
Feb-01-21 06:00AM  
Exact Sciences to participate in February investor conferences
PR Newswire
06:00AM  
Exact Sciences schedules fourth quarter 2020 earnings call
PR Newswire
Jan-26-21 10:19AM  
Exact Sciences Falls Back
Investor's Business Daily Video -8.37%
Jan-24-21 11:11PM  
Apogee Enterprises, Inc. (NASDAQ:APOG) Passed Our Checks, And It's About To Pay A US$0.20 Dividend
Simply Wall St.
Jan-14-21 12:34PM  
15 Best Undervalued Stocks to Buy Now
Insider Monkey
12:16PM  
Exact Sciences (EXAS) Posts Solid Preliminary Q4 Testing Revenues
Zacks
Jan-13-21 02:45PM  
Exact Sciences Licenses Targeted Digital Sequencing Method to Extend Leadership in Precision Oncology
PR Newswire
07:00AM  
Sidoti Virtual Investor Conference
ACCESSWIRE
06:30AM  
Apogee Enterprises Announces Seven Percent Increase to Quarterly Dividend
Business Wire
Jan-12-21 02:45PM  
New Prospective Data Demonstrate Low False-Positive Rate for Screening Average-Risk People Age 45-49 for Colorectal Cancer with Cologuard®
PR Newswire
12:48PM  
Exact Sciences Scores Relative Strength Rating Upgrade; Hits Key Threshold
Investor's Business Daily
08:32AM  
Exact Sciences (EXAS) Soars: Stock Adds 9.8% in Session
Zacks
Jan-11-21 11:01AM  
Why Exact Sciences Stock Is Soaring Today
Motley Fool +9.84%
Jan-10-21 07:30PM  
Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
PR Newswire
Jan-08-21 07:00AM  
Why The Covid Pandemic Will Be A Boon For These Health Care Stocks
Investor's Business Daily
Jan-05-21 08:25AM  
Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a Leader in Blood-Based, Multi-Cancer Screening
PR Newswire
06:30AM  
Apogee Enterprises Reports Grant of Inducement Award
Business Wire
Dec-28-20 06:00AM  
Exact Sciences to participate in J.P. Morgan Healthcare Conference
PR Newswire
Dec-26-20 05:17PM  
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily
Dec-22-20 04:42PM  
Is EXAS A Good Stock To Buy According To Hedge Funds?
Insider Monkey
05:41AM  
Earnings Beat: Apogee Enterprises, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Simply Wall St.
Dec-21-20 05:10PM  
Dow Jones Futures: Stimulus Deal Vote Due After Stock Market Rally, Apple, AMD, Nio, Uber Rebound From Key Level; Tesla Stock Is Biggest S&P 500 Loser
Investor's Business Daily
10:08AM  
Exact Sciences Breaks Out
Investor's Business Daily Video
06:30AM  
Apogee Enterprises Appoints Ty R. Silberhorn as CEO
Business Wire
Dec-18-20 07:15AM  
Apogee Enterprises, Inc. to Host Earnings Call
ACCESSWIRE
06:30AM  
Apogee Enterprises Reports Fiscal 2021 Third-quarter Results
Business Wire
Dec-17-20 11:45PM  
A Look At The Fair Value Of Apogee Enterprises, Inc. (NASDAQ:APOG)
Simply Wall St. +6.84%
04:44PM  
This IBD Stock Of The Day Hasn't Broken Out Yet But It's Actionable Now
Investor's Business Daily
10:17AM  
Exact Sciences Sets Up For Breakout
Investor's Business Daily Video
Dec-11-20 06:23PM  
Should I Buy Apogee Enterprises, Inc. (APOG)?
Insider Monkey
09:00AM  
New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
PR Newswire
Dec-09-20 12:30PM  
Is EXACT Sciences Corp (EXAS) a Smart Long-term Buy?
Insider Monkey
09:00AM  
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer
PR Newswire
09:00AM  
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer
CNW Group
Dec-03-20 06:30AM  
Apogee Enterprises to Report Fiscal 2021 Third Quarter Financial Results
Business Wire +5.03%
Nov-23-20 06:00AM  
Exact Sciences to participate in December investor conference
PR Newswire
Nov-14-20 12:05PM  
Stock Market Rally At Highs, But Who Will Lead? Google, Microsoft, Visa, JD.com, Moderna Coronavirus Vaccine In Focus
Investor's Business Daily
08:08AM  
Forget Apple! Buy These 2 High-Growth Stocks Instead
Motley Fool
Nov-13-20 11:11AM  
Exact Sciences Looking Tight
Investor's Business Daily Video
08:30AM  
Wild Ride For Illumina Stock Shows Promise, Challenge Of Multi-Cancer Blood Tests
Investor's Business Daily
Nov-08-20 09:06PM  
Here's Why Exact Sciences Jumped 21.5% in October
Motley Fool
Nov-02-20 10:45AM  
Exact Sciences (EXAS) Loses 5.6% Despite Beating Q3 Earnings
Zacks
06:00AM  
Exact Sciences to participate in November investor conferences
PR Newswire
Oct-28-20 12:16PM  
Investing Isn't an 'Exact Science' but the Charts Do Look Good
TheStreet.com
10:24AM  
Exact Sciences Stock Cut by Citi to Neutral on Valuation
TheStreet.com
07:41AM  
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
Benzinga
Oct-27-20 04:35PM  
Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45
PR Newswire +23.04%
03:03PM  
Why Exact Sciences $2.15 Billion Deal Has Investors Excited About Cancer-Screening Technology
Barrons.com
02:09PM  
Here's Why Exact Sciences Stock Rocketed Higher Today
Motley Fool
12:44PM  
Exact Sciences Soars on $2.15 Billion Deal for Testing Firm
Bloomberg
11:26AM  
Exact Sciences Surges on $2.5 Billion Deal to Buy Thrive
TheStreet.com
10:29AM  
Exact Sciences's Debt Overview
Benzinga
10:25AM  
Exact Sciences (EXAS) Reports Q3 Loss, Tops Revenue Estimates
Zacks
09:55AM  
Looking Into Exact Sciences's Return On Capital Employed
Benzinga
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEOMay 03Sale131.0919,2402,522,172757,496May 05 04:49 PM
Conroy Kevin TPresident and CEOApr 01Sale132.3022,7553,010,487776,408Apr 05 04:54 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 11Option Exercise26.0643,2411,126,92681,608Mar 15 04:37 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 11Sale130.0043,2415,621,33038,367Mar 15 04:37 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 08Option Exercise21.684,61299,98838,367Mar 10 05:22 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 05Sale121.3311,7351,423,80833,755Mar 08 05:48 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 03Sale135.022,632355,37338,361Mar 05 04:49 PM
COWARD D SCOTTChief Administrative OfficerMar 03Sale135.022,664359,6931,301Mar 05 04:48 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 02Sale138.422,524349,37245,490Mar 03 08:34 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 02Sale139.244,230588,98940,993Mar 03 08:33 PM
COWARD D SCOTTChief Administrative OfficerMar 02Sale139.234,126574,4573,965Mar 03 08:30 PM
Conroy Kevin TPresident and CEOMar 02Sale138.429,7961,355,962799,163Mar 03 08:28 PM
Condella SarahSVP, Human ResourcesMar 02Sale138.421,679232,40774,052Mar 03 08:27 PM
COWARD D SCOTTChief Administrative OfficerMar 01Option Exercise44.374,175185,2457,241Mar 02 06:56 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 01Option Exercise0.005,025048,014Mar 03 08:34 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01Option Exercise0.005,025045,223Mar 03 08:33 PM
COWARD D SCOTTChief Administrative OfficerMar 01Option Exercise0.005,02508,091Mar 03 08:30 PM
Conroy Kevin TPresident and CEOMar 01Option Exercise0.0020,5750808,959Mar 03 08:28 PM
Condella SarahSVP, Human ResourcesMar 01Option Exercise0.003,525075,731Mar 03 08:27 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 01Sale137.441,603220,31642,989Mar 02 07:00 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01Sale136.918,4031,150,48640,198Mar 02 06:59 PM
Condella SarahSVP, Human ResourcesMar 01Sale137.441,098150,90972,206Mar 02 06:58 PM
Conroy Kevin TPresident and CEOMar 01Sale136.8831,2934,283,387788,384Mar 02 06:56 PM
COWARD D SCOTTChief Administrative OfficerMar 01Sale136.965,673776,9833,066Mar 02 06:56 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.009,3120819,677Mar 02 06:56 PM
COWARD D SCOTTChief Administrative OfficerFeb 26Option Exercise0.003,26304,564Mar 02 06:56 PM
WYZGA MICHAEL SDirectorFeb 26Option Exercise26.9810,108272,71421,579Mar 02 07:00 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Option Exercise0.003,437048,601Mar 02 06:59 PM
Condella SarahSVP, Human ResourcesFeb 26Option Exercise0.002,357073,304Mar 02 06:58 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 26Option Exercise0.003,263044,592Mar 02 07:00 PM
WYZGA MICHAEL SDirectorFeb 26Sale130.1119,0212,474,8222,558Mar 02 07:00 PM
Doyle James EdwardDirectorFeb 26Sale130.112,000260,22030,459Mar 02 06:57 PM
COWARD D SCOTTChief Administrative OfficerFeb 25Sale132.966,788902,5321,301Mar 01 06:10 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 24Sale136.305,842796,26541,329Feb 25 07:24 PM
COWARD D SCOTTChief Administrative OfficerFeb 24Sale136.306,062826,2518,089Feb 25 07:23 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Sale136.304,449606,39945,164Feb 25 07:24 PM
Conroy Kevin TPresident and CEOFeb 24Sale136.3016,4202,238,046810,365Feb 25 07:22 PM
Condella SarahSVP, Human ResourcesFeb 24Sale136.302,057280,36970,947Feb 25 07:21 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Option Exercise12.8631,600406,50032,901Feb 25 07:23 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.009,300049,613Feb 25 07:24 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0034,3250826,785Feb 25 07:22 PM
Condella SarahSVP, Human ResourcesFeb 23Option Exercise0.004,300073,004Feb 25 07:21 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 23Option Exercise0.0011,575047,171Feb 25 07:24 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Sale136.5118,7502,559,56214,151Feb 25 07:23 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 19Sale143.381,696243,1725,445Feb 22 06:01 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise0.003,64907,141Feb 22 06:01 PM
COWARD D SCOTTChief Administrative OfficerFeb 18Sale140.791,980278,7641,301Feb 22 06:00 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 17Sale142.662,020288,17340,313Feb 18 07:30 PM
COWARD D SCOTTChief Administrative OfficerFeb 17Sale142.661,992284,1793,281Feb 18 07:28 PM
Conroy Kevin TPresident and CEOFeb 17Sale142.6615,8252,257,594792,460Feb 18 07:27 PM
Condella SarahSVP, Human ResourcesFeb 17Sale142.661,033147,36868,704Feb 18 07:25 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 17Sale142.661,033147,3683,492Feb 18 07:33 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 17Sale142.662,131304,00835,596Feb 18 07:31 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 16Option Exercise0.003,972042,333Feb 18 07:30 PM
COWARD D SCOTTChief Administrative OfficerFeb 16Option Exercise0.003,97205,273Feb 18 07:28 PM
Conroy Kevin TPresident and CEOFeb 16Option Exercise0.0031,1320808,285Feb 18 07:27 PM
Condella SarahSVP, Human ResourcesFeb 16Option Exercise0.002,030069,737Feb 18 07:25 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 16Option Exercise0.002,03004,525Feb 18 07:33 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 16Option Exercise0.003,972037,727Feb 18 07:31 PM
Conroy Kevin TPresident and CEOFeb 05Option Exercise5.7017,54399,995777,153Feb 09 04:34 PM
Conroy Kevin TPresident and CEOFeb 01Sale138.0730,3444,189,596759,610Feb 03 04:20 PM
Conroy Kevin TPresident and CEOJan 04Sale128.7431,8144,095,734825,704Jan 07 09:05 AM
Zanotti Katherine SDirectorDec 14Sale132.0620,0002,641,18221,907Dec 14 06:15 PM
Conroy Kevin TPresident and CEODec 01Sale124.5630,5773,808,660857,518Dec 02 06:28 PM
Conroy Kevin TPresident and CEONov 02Sale121.1132,8193,974,738888,095Nov 03 04:49 PM
Conroy Kevin TPresident and CEOOct 01Sale103.5527,4252,839,829920,914Oct 02 05:54 PM
Hoof TorstenGeneral Manager, InternationalSep 24Option Exercise41.534,401182,7746,418Sep 28 04:33 PM
Hoof TorstenGeneral Manager, InternationalSep 24Sale80.004,401352,0802,017Sep 28 04:33 PM
Conroy Kevin TPresident and CEOSep 01Sale75.0319,9271,495,123948,339Sep 02 04:32 PM
Hoof TorstenGeneral Manager, InternationalAug 19Option Exercise43.401,51665,7949,981Aug 21 04:31 PM
Hoof TorstenGeneral Manager, InternationalAug 19Sale84.907,964676,1442,017Aug 21 04:31 PM
Hoof TorstenGeneral Manager, InternationalAug 17Option Exercise0.002,55108,465Aug 19 04:15 PM
Conroy Kevin TPresident and CEOAug 03Sale93.8025,1982,363,560968,266Aug 04 05:18 PM
Zanotti Katherine SDirectorJul 31Option Exercise8.5221,029179,16762,936Aug 04 04:54 PM
LEVANGIE DANIEL JDirectorJul 31Option Exercise9.309,86591,69924,881Aug 04 04:58 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Option Exercise21.686,638143,91275,861Aug 04 05:02 PM
Carey Thomas D.DirectorJul 31Option Exercise9.2415,620144,32952,492Aug 04 05:21 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Sale93.8337,5003,518,77138,361Aug 04 05:02 PM
Carey Thomas D.DirectorJul 31Sale94.0030,6202,878,28021,872Aug 04 05:21 PM
LEVANGIE DANIEL JDirectorJul 31Sale94.009,865927,31015,016Aug 04 04:58 PM
Zanotti Katherine SDirectorJul 31Sale94.0021,0291,976,72641,907Aug 04 04:54 PM
Doyle James EdwardDirectorJul 31Sale94.002,539238,66632,459Aug 04 04:45 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Sale95.588,746835,94369,223Jul 30 08:18 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 28Option Exercise94.8118,7501,777,68877,969Jul 30 08:18 PM
Zanotti Katherine SDirectorJul 28Sale96.131,164111,89541,907Jul 30 06:49 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.